ADAMI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.906
EU - Europa 1.753
AS - Asia 841
SA - Sud America 7
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.517
Nazione #
US - Stati Uniti d'America 1.897
CN - Cina 663
GB - Regno Unito 456
IT - Italia 262
DE - Germania 223
SE - Svezia 223
IE - Irlanda 213
FR - Francia 190
SG - Singapore 84
RU - Federazione Russa 62
FI - Finlandia 58
JP - Giappone 37
UA - Ucraina 20
KR - Corea 12
TR - Turchia 12
VN - Vietnam 12
AT - Austria 9
CA - Canada 9
NL - Olanda 8
BE - Belgio 7
HK - Hong Kong 6
PT - Portogallo 6
IR - Iran 5
IN - India 4
AU - Australia 3
BR - Brasile 3
CH - Svizzera 3
LV - Lettonia 3
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A1 - Anonimo 1
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KW - Kuwait 1
MA - Marocco 1
PE - Perù 1
PL - Polonia 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 4.517
Città #
Chandler 488
Southend 448
Dublin 208
Ashburn 171
Beijing 121
Jacksonville 100
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Bologna 65
Ann Arbor 61
New York 59
Jinan 58
Shenyang 53
Singapore 52
Nanjing 46
Sindelfingen 46
Verona 46
Helsinki 41
Tokyo 36
Woodbridge 35
Hebei 34
Seattle 33
Tianjin 28
Washington 27
Zhengzhou 26
Taiyuan 22
Changsha 21
Haikou 21
Hangzhou 20
Ningbo 19
Houston 17
Nanchang 17
Dongguan 16
Fairfield 15
Guangzhou 15
Jiaxing 15
Redwood City 15
San Francisco 12
Taizhou 12
Norwalk 11
Seoul 11
Venice 11
Milan 9
Falls Church 8
Fuzhou 8
Miami 8
Vienna 8
Brussels 7
Dearborn 7
Hong Kong 6
Lanzhou 6
Los Angeles 6
Boydton 5
Chicago 5
Dong Ket 5
Düsseldorf 5
Kent 5
Rome 5
Bari 4
Easton 4
Esslingen am Neckar 4
Falkenstein 4
Lappeenranta 4
Renton 4
Shanghai 4
Toronto 4
Biandronno 3
Cerea 3
Detroit 3
Faenza 3
Luino 3
Mehlingen 3
Nürnberg 3
São Paulo 3
Acquaviva Picena 2
Ardabil 2
Bergamo 2
Bratislava 2
Calais 2
Campobasso 2
Cascina 2
Chapel Hill 2
Chennai 2
Chiampo 2
Isola della Scala 2
Leawood 2
Lecce 2
Legnaro 2
London 2
Mesa 2
Minerbio 2
Muizenberg 2
Novokuznetsk 2
Offlaga 2
Ottawa 2
Pedrengo 2
Pompei 2
Riva 2
Totale 3.075
Nome #
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 143
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 116
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 111
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 105
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 104
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 99
Anti-CCP antibodies and bone 95
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 94
Could γ\δ T-cells explain zoledronic acid adverse events? 90
Safety issues and adverse reactions with osteoporosis management 89
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 89
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 87
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 83
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 82
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 81
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 81
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 80
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 79
Rheumatoid arthritis, γδ T cells and bisphosphonates 77
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 76
The obesity paradox and osteoporosis 73
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 68
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 67
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 65
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 64
Association between environmental air pollution and rheumatoid arthritis flares 64
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 63
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 63
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 62
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 61
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 58
Correction to: The obesity paradox and osteoporosis 57
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 57
Osteoporosis in Rheumatic Diseases 55
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 54
Gender disparity in authorship of guidelines and recommendations in rheumatology 52
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 48
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 48
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 48
Calcium and vitamin D supplementation: when and why 47
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 47
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 46
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 45
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 45
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 45
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 44
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 43
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 43
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 42
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 42
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 42
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 41
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 41
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 41
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 40
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 39
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 39
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 39
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 39
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 39
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 37
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 34
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 34
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 33
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 32
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 30
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 29
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 29
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 27
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 26
Glucocorticoid-induced osteoporosis update 24
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 24
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 24
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 23
Association between acute exposure to environmental air pollution and fragility hip fractures 23
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis 23
Pragmatic Clinical Trials in Osteoporosis 22
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 21
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 21
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 20
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 19
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 18
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 18
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 17
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 14
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 14
Balancing benefits and risks in the era of biologics 13
Regulation of bone mass in inflammatory diseases 12
Bone health status evaluation in men by means of REMS technology 12
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 12
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 11
Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic 11
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 11
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021 10
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 10
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 8
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review 8
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 8
Mining the pathogenesis of rheumatoid arthritis, the leading role of the environment 8
Fracture in clinical studies of tofacitinib in rheumatoid arthritis 7
Totale 4.654
Categoria #
all - tutte 19.871
article - articoli 19.871
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 0 2
2019/2020390 44 8 7 58 39 50 37 6 36 24 28 53
2020/2021656 96 132 22 114 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024946 40 70 89 125 80 202 54 44 30 43 151 18
Totale 4.719